Pre-Engraftment Syndrome After Autologous Stem Cell Transplantation in Relapsed or Refractory Hodgkin Lymphoma: An Association with Prior PD-1 Inhibitor Exposure.

Medicina (Kaunas) · 2026 · PMC13118044 · PMID 42075609

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In their analysis, several potential risk factors—including the number of infused stem cells, duration of ICI exposure, timing of ICI therapy in relation to autologous transplantation, and plerixafor use—were systematically evaluated but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.